Sunday, July 21, 2019
Home News Medical News

Medical News

The Food and Drug Administration (FDA) has approved Teva’s AirDuo Digihaler, a combination of fluticasone and salmeterol, which can be connected to mobile. The Digihaler provides information on inhaler use to patients, which can be shared with their doctor to assess the treatment adherence and progress.
After launching BPM Core, Withings, a French electronics company, has launched BPM Connect, a device that captures blood pressure, ECG and stethoscope readings. The new device also helps detect Afib, or atrial fibrillation, without using a smartphone.
Officials at the Georgia Department of Public Health said three guests who stayed at a prominent Atlanta Hotel have been diagnosed with Legionnaires' disease. The officials have been working with other public health officials and experts to test the hotel for the pathogenic bacterium that caused Legionnaires' to those three guests.
According to a new study, anorexia nervosa, an eating disorder, is more than just a mental health issue. Researchers found that people with anorexia nervosa have genetic mutations that are associated with psychiatric disorders as well as metabolism, suggesting new interventions for people with anorexia.
Fluoroquinolones are a type of antibiotics that are often prescribed to treat a variety of bacterial infections. However, it is imperative to know that inappropriate or unnecessary use of such drugs can increase the risk of antibiotic resistance. Check with your doctor to know about the potential benefits and risks of using fluoroquinolones.
American Regent, a New York-based pharmaceutical company, has launched and made available its FDA-approved product called Selenious Acid Injection, USP for adults and children for parenteral nutrition. The product contains selenium, an antioxidant that helps reduce oxidative stress, subside inflammation, and improve the immune system.
The U.S. Food and Drug Administration (FDA) has approved selinexor, brand name Xpovio, in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma (RRMM). Manufactured by Karyopharm, selinexor has been found effective for treating RRMM when given in association with dexamethasone.